K. Jordan

发表

Novel nicotinic acetylcholine receptor agonists containing carbonyl moiety as a hydrogen bond acceptor.

D. Kombo, A. Mazurov, T. Hauser, 2013, Bioorganic & medicinal chemistry letters.

Effects of the nootropic AWD 52-39 on the blood-brain transfer of leucine, choline and glucose in rats after 14-d exposure to ethanol.

P. Brust, K. Jordan, 1992, Die Pharmazie.

Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective α4β2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders.

D. Kombo, A. Mazurov, J. Speake, 2012, Journal of medicinal chemistry.

TC‐5214 (S‐(+)‐Mecamylamine): A Neuronal Nicotinic Receptor Modulator with Antidepressant Activity

Jianxun Xie, M. Bencherif, G. Gatto, 2008, CNS neuroscience & therapeutics.

Unilateral 6-OHDA th-fgfr1(tk-) mouse model supports the role of FGFs in Parkinson's disease and the effects of nicotine and L-DOPA on spontaneous motor impairments

M. Bencherif, E. Stachowiak, M. Stachowiak, 2012 .

Workshop Series to Identify, Discuss, and Develop Recommendations for the Optimal Generation and Use of In Vitro Assay Data for Tobacco Product Evaluation: Phase 1 Genotoxicity Assays

Martha M. Moore, Julie Clements, Pooja Desai, 2020, Applied In Vitro Toxicology.

TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia.

R. Papke, T. Hauser, M. Bencherif, 2009, Biochemical pharmacology.

α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats

J. Strachan, M. Quik, T. Bordia, 2013, Neuropharmacology.

Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease

M. Bencherif, E. Stachowiak, M. Stachowiak, 2013, Pharmacology Biochemistry and Behavior.

Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of α4β2* receptors.

A. Mazurov, J. Speake, T. Hauser, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Systemic administration of an alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley rats.

S. Maier, L. Watkins, J. Speake, 2012, The journal of pain : official journal of the American Pain Society.

Characterization of the discriminative stimulus effects of N-methyl-D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey (Macaca fascicularis)

K. Grant, J. Vivian, K. Szeliga, 2002, Psychopharmacology.

TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque

J. Brotchie, S. Fox, K. Szeliga, 2013, Neuropharmacology.

Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of α4β2* receptors.

A. Mazurov, J. Speake, T. Hauser, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Tc-5619: an Alpha7 Neuronal Nicotinic Receptor-selective Agonist That Demonstrates Efficacy in Animal Models of the Positive and Negative Symptoms and Cognitive Dysfunction of Schizophrenia Nih Public Access Author Manuscript

R. Papke, M. Bencherif, E. Stachowiak, 2022 .